MIRA Stock Analysis: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$0.96
-0.01 (-1.24%)
▼
5d:
-2.43%
30d:
-8.29%
90d:
-16.98%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $0.96, which is considered oversold relative to its 30-day fair value range of $0.99 to $1.07.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.93, while resistance sits at $1.06.
Market Sentiment: MIRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.75 (+1743.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.93, while resistance sits at $1.06.
Market Sentiment: MIRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.75 (+1743.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.99 -
$1.07
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1743.2% below Wall St target ($17.75)
Trading Range Analysis
30-Day Trading Range
$0.99 -
$1.07
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.93
Resistance Level
$1.07
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.35
Wall Street Target
$17.75
(+1743.2%)
Share & Embed Analysis
Last updated: May 16, 2026 2:54 AM ET
Data refreshes hourly during market hours. Next update: 3:54 AM
Data refreshes hourly during market hours. Next update: 3:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1209 | 62 BUY |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 61 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$252 | 65 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$217 | 63 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$353 | 60 HOLD |
